Media

Keep up to date with all the latest news and updates from Virax Biolabs.

June 15, 2023

Better Health Care Tests, Faster (featuring Tomasz George)

June 14, 2023

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

June 1, 2023

Virax Biolabs readies clinical performance study of ViraxImmune Platform

May 4, 2023

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

April 19, 2023

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

April 18, 2023

The Immune System and the Role of T Cells

By Dr Clément Monteil When the human body encounters an external infection such as a virus, bacteria or parasite, it activates a complex and coordinated defence mechanism to identify, target

March 8, 2023

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

March 7, 2023

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

February 16, 2023

VRAX: INITIATION: Innovative Biotechnology Company Developing A Potentially Groundbreaking Immunology Platform Based Around Proprietary T-Cell Testing Technology

by Thomas Kerr, CFA

February 7, 2023

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

February 6, 2023

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

February 2, 2023

Media

Better Health Care Tests, Faster (featuring Tomasz George)

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Virax Biolabs readies clinical performance study of ViraxImmune Platform

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

The Immune System and the Role of T Cells

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

VRAX: INITIATION: Innovative Biotechnology Company Developing A Potentially Groundbreaking Immunology Platform Based Around Proprietary T-Cell Testing Technology

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Quick links

Subscribe to Our Newsletter